Announced Wed, 8 Jul · 16:05 IST
Quarterly dematerialisation compliance certificate filed with exchanges
Compliance View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹2409.80
prior close
₹2410.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.1+0.3+1.5+1.0+0.5+2.3+3.0+4.0+3.7————
Up moveDown movePending
AI summary
GlaxoSmithKline Pharmaceuticals has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for Q1 FY27 (quarter ended 30 June 2026). The certificate, issued by Registrar KFin Technologies, confirms that share dematerialisation requests received during the quarter were processed, physical certificates were cancelled, and the depository was recorded as the registered owner in the member register within 30 days. This is a routine, mandatory regulatory filing and not a business event.
Likely market impact
Routine regulatory compliance filing with no material impact on shareholders, operations, or stock price.